市場調查報告書
商品編碼
1084758

藥物研發外包的市場規模、佔有率、趨勢、預測 (2022年∼2028年):各藥物類型、服務、用途、終端用戶、地區

Outsourced Drug Discovery Market by Drug Type, by Services, by Application, by End Users, by Region - Size, Share, Trends, and Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

主要加入企業採用的新策略預計促進全球藥物研發外包市場成長。還有企業聯盟活動的擴大也預計促進市場成長。

本報告提供全球藥物研發外包的市場調查,市場定義和概要,市場成長的各種影響因素分析,法律制度,技術趨勢,市場規模的變化、預測,各種區分、各地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

第3章 市場動態、法律規章、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的展開
  • 技術的進步
  • 歷史概要
  • M&A
  • 法規情境
  • 波特分析
  • PEST分析

第4章 全球藥物研發外包市場:各藥物類型

  • 低分子藥
  • 高分子藥

第5章 全球藥物研發外包市場:各類服務

  • 前臨床開發
  • 目標驗證&功能性資訊學
  • 目標識別&篩檢
  • 領導特定、候補的最佳化
  • 其他

第6章 全球藥物研發外包市場:各用途

  • 腫瘤
  • 眼科
  • 血液
  • 免疫調節
  • 抗感染藥
  • 皮膚科
  • 神經
  • 呼吸系統
  • 心臟病
  • 其他

第7章 全球藥物研發外包市場:各終端用戶

  • 製藥及生物科技企業
  • CRO
  • CMO

第8章 全球藥物研發外包市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第9章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Aurigene Accelerating Discovery
    • Bioduro LLC.
    • Charles River Laboratories(CRL)
    • TCG Lifesciences
    • Evotec AG
    • Syngene International Ltd.
    • Jubilant Biosys Ltd.
    • Pharmaron Inc.
    • Shanghai Medicilon Inc.
    • Sundia Meditech Co. Ltd.
  • 分析師的見解

第10章 Section

目錄
Product Code: CMI2847

Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

Market Dynamics

New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.

Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2021, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.

Key features of the study:

  • This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global outsourced drug discovery market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Outsourced Drug Discovery Market, By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
  • Global Outsourced Drug Discovery market, By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
  • Global Outsourced Drug Discovery Market, By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
  • Global Outsourced Drug Discovery market, By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
  • Global Outsourced Drug Discovery market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Middle East
      • By Country/Region:
    • GCC
    • Israel
    • Rest of Middle East
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
  • Company Profiles
    • Aurigene Accelerating Discovery,*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bioduro LLC.
    • Charles River Laboratories (CRL)
    • TCG Lifesciences
    • Evotec AG
    • Syngene International Ltd.
    • Jubilant Biosys Ltd.
    • Pharmaron Inc.
    • Shanghai Medicilon Inc.
    • Sundia Meditech Co. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Services
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Outsourced Drug Discovery Market, By Drug Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Small Molecule Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Large Molecule Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Outsourced Drug Discovery Market, By Services, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Preclinical Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Target Validation and Functional Informatics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Target Identification and Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Lead Identification and Candidate Optimization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Outsourced Drug Discovery Market, By Application, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hematology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Immunomodulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Anti-Infective Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Pulmonology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Outsourced Drug Discovery Market, By End Users, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Pharmaceutical and Biotechnological Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Contract Research Organization (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Contract Manufacturing Organization (CMO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Outsourced Drug Discovery Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Aurigene Accelerating Discovery
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bioduro LLC.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Charles River Laboratories (CRL)
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • TCG Lifesciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Evotec AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Syngene International Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Jubilant Biosys Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pharmaron Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Shanghai Medicilon Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Sundia Meditech Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact